유세포분석 시장 - 예측(2026-2031년)

The flow cytometry market, at a 7.34% CAGR, is projected to increase from USD 6.196 billion in 2025 to USD 9.479 billion in 2031.

The flow cytometry market is experiencing significant expansion, driven by its critical role in both clinical diagnostics and advanced research. This technology, which enables the rapid analysis of single cells to measure physical and chemical characteristics, has become indispensable for applications ranging from immunophenotyping to cell sorting. The market's growth is propelled by the increasing prevalence of specific diseases, continuous technological advancements, and substantial support from governmental and research institutions.

A primary driver of market growth is the extensive and diverse application portfolio of flow cytometry. The technology is utilized for analyzing a wide variety of specimens, including bone marrow, whole blood, and solid tissues. Its capabilities extend to immunophenotyping, DNA/RNA content analysis via fluorescent dyes, and the characterization of heterogeneous cell populations. This versatility makes it a cornerstone tool in healthcare for diagnosing and monitoring conditions such as leukemia, lymphoma, and autoimmune disorders, as well as a vital instrument in life sciences research, thereby ensuring sustained demand.

The rising global burden of specific diseases is a major factor bolstering market expansion. Flow cytometry plays an essential role in the management and study of HIV, where it is used in conjunction with PCR for viral subtyping and quantification. Similarly, its application in oncology for cancer classification and monitoring continues to be a significant demand driver. Furthermore, the technology is crucial for diagnosing and researching a wide spectrum of primary and secondary immunodeficiency disorders, conditions that affect millions worldwide and often require sophisticated cellular analysis for proper characterization and management.

Substantial research initiatives and government funding are accelerating market development. Public health goals aimed at reducing HIV incidence and significant grants for stem cell and regenerative medicine research create a favorable environment for the adoption of advanced analytical technologies. These initiatives often directly fund the infrastructure and consumables that drive flow cytometry usage. Concurrently, technological innovation, particularly the trend toward automation in sample preparation and system operation, is enhancing efficiency, standardizing workflows, and improving reproducibility. This evolution makes the technology more accessible and reliable for a broader range of laboratory settings.

The market presents considerable opportunities for both established players and new entrants. Ongoing technological advancements, coupled with government-backed programs that encourage technology adoption in biomanufacturing and provide specialized training, are lowering barriers to entry. These developments enable new participants to enter the market with a focus on specialized applications, services, or innovative product features that address the growing demand for standardized and compliant analytical tools.

Geographically, North America is expected to witness notable growth and maintain a significant market share. This leadership is attributed to the region's higher prevalence of key diseases such as HIV and cancer, a robust and technologically advanced healthcare infrastructure, and substantial healthcare expenditure. The presence of leading market players and a strong culture of biomedical research further consolidate the region's dominant position, driving the adoption of flow cytometry in both diagnostic centers and research institutions.

The competitive landscape includes specialized firms such as Apogee Flow Systems and diversified global leaders like Bio-Rad Laboratories and Sysmex Corp. These companies are focused on developing comprehensive solutions that range from high-performance cytometers for specific applications to fully automated, integrated systems designed for clinical diagnostic environments. A key industry trend is the enhancement of software capabilities to ensure data integrity and compliance with manufacturing guidelines, reflecting the market's maturation and the increasing need for reliable, standardized data in regulated environments.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Flow Cytometry Market Segmentation:

• By Product Type
• Instruments
• Reagents
• By Technology
• Laser-Based
• Impedance-Based
• By Application
• Molecular Biology
• Pathology
• Immunology
• Others
• By End-User
• Hospitals & Clinics
• Academic & Research Institutes
• Others
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Italy
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. FLOW CYTOMETRY MARKET BY PRODUCT TYPE

• 5.1. Introduction
• 5.2. Instruments
• 5.3. Reagents

6. FLOW CYTOMETRY MARKET BY TECHNOLOGY

• 6.1. Introduction
• 6.2. Laser-Based
• 6.3. Impedance-Based

7. FLOW CYTOMETRY MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Molecular Biology
• 7.3. Pathlogy
• 7.4. Immunology
• 7.5. Others

8. FLOW CYTOMETRY MARKET BY END-USER

• 8.1. Introduction
• 8.2. Hospitals & Clinics
• 8.3. Academic & Research Institutes
• 8.4. Others

9. FLOW CYTOMETRY MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Spain
  • 9.4.5. Italy
  • 9.4.6. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Israel
  • 9.5.4. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. South Korea
  • 9.6.5. Indonesia
  • 9.6.6. Thailand
  • 9.6.7. Taiwan
  • 9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Danaher Corporation
• 11.2. Becton Dickinson and Company
• 11.3. Sysmex Corp.
• 11.4. Agilent Technologies, Inc.
• 11.5. Apogee Flow Systems Ltd.
• 11.6. Bio-Rad Laboratories, Inc.
• 11.7. Thermo Fisher Scientific, Inc.
• 11.8. Stratedigm, Inc.
• 11.9. Miltenyi Biotec
• 11.10. Diasorin

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key Benefits for the Stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations